atropine and pralidoxime chloride

FDA Drug Profile — ATNAA atropine and pralidoxime chloride Auto-Injector, DuoDote

atropine and pralidoxime chloride is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including ATNAA atropine and pralidoxime chloride Auto-Injector, DuoDote. Available dosage form: kit.

Drug details

Generic Name
atropine and pralidoxime chloride
Brand Names
ATNAA atropine and pralidoxime chloride Auto-Injector, DuoDote
Application Number
NDA021175
Sponsor
Meridian Medical Technologies, LLC
NDC Codes
3
Dosage Forms
KIT
Routes
INTRAMUSCULAR

Indications and Usage

1 INDICATIONS AND USAGE ATNAA is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ATNAA, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.